Severe respiratory disease in infants with cystic fibrosis.
D000138:Acidosis / Q000209:etiology; D000142:Acidosis, Respiratory / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001344:Autopsy; D003550:Cystic Fibrosis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006813:Humidity; D006854:Hydrocortisone / Q000627:therapeutic use; D000860:Hypoxia / Q000175:diagnosis; D007223:Infant; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D011241:Prednisone / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000188:drug therapy; D001261:Pulmonary Atelectasis / Q000000981:diagnostic imaging / Q000209:etiology; D011859:Radiography; D012131:Respiratory Insufficiency / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000209:etiology*; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D010100:Oxygen; D011241:Prednisone; D006854:Hydrocortisone